!

INFINITY adopted by ChemConnection EmulTech proudly announces that ChemConnection acquired the INFINITY platform. ChemConnection will use the system to further expand their formulation development services in the field of drug loaded particle formulations. INFINITY will be used for the development of microparticle based sustained release depot formulations. Gerjan Kemperman, CEO and founder of ChemConnection, says: “We are really pleased with the INFINITY at our site. The equipment has already proven itself in over 30 projects at EmulTech. We believe the INFINITY is unique in process control, reproducibility, aseptic production and scalability. The combination with our extensive formulation development and API manufacturing expertise will allow us to address pharmaceutical companies with a need for complex drug delivery formulations.” Fränk de Jong, CEO and co-founder of EmulTech, says: “It is great to support ChemConnection with extending their proposition. They have a strong history in liposomal and nano- and microparticle formulations. They also provide unique development services in formulating highly potent APIs. The fact that they are offering both pre-clinical and GMP development and manufacturing services provide pharmaceutical companies with an excellent partner to work with. We are therefore exited that they adopted our equipment to service their customers.” The INFINITY platform is a range of microfluidic encapsulation equipment for the development and production of uniform micro-particles and micro-emulsions. The unique process control reduces development time and yields better products. The excellent scalability of the technology ensures market relevant production capabilities. EmulTech developed and markets the INFINITY platform. Founded in 2009, the Eindhoven based company currently serves a range of Big Pharma companies, Contract Research Organizations and universities in Europe, USA and Asia. ChemConnection is an award winning contract research and manufacturing organization (CRO/CMO) offering process development, cGMP manufacturing, and full analytical development and method validation for active pharmaceutical ingredients (APIs) & nano- and micro- medicine formulations. Based upon the legacy Organon/MSD experience and facilities, ChemConnection has established a strong track record in the cGMP manufacture of drug loaded liposomes and polymeric carriers. The high containment facilities allow for the manufacturing of highly potent formulations for use in oncology, inflammation and CNS. For more information on EmulTech and its INFINITY platform (www.EmulTech.nl) or ChemConnection (www.chemconnection.eu) visit our websites or contact us on: +31 40 751 6161 (EmulTech) or +31 412 846 024 (ChemConnection).